Balingit, Kemberly M.

HRN: 27-38-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/05/2025
08/06/2025
IV
500mg
Q8
S/p CS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines